{
    "organizations": [],
    "uuid": "062176c131af3bdd61b0602c83e269e128fc1448",
    "author": "Charley Grant",
    "url": "https://www.wsj.com/articles/biotech-gets-a-reality-check-1523030490",
    "ord_in_thread": 0,
    "title": "Biotech Gets a Reality Check",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "A major source of biotech sector optimism just took a significant hit.\nThe drug industry has poured billions of dollars into novel drugs that fight cancer, generating exciting results for patients and significant value for biotech investors. It is a problem, then, when potential blockbuster drugs miss the mark.\nCancer specialist Incyte announced... ",
    "published": "2018-04-07T00:29:00.000+03:00",
    "crawled": "2018-04-07T03:53:38.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "major",
        "source",
        "biotech",
        "sector",
        "optimism",
        "took",
        "significant",
        "hit",
        "drug",
        "industry",
        "poured",
        "billion",
        "dollar",
        "novel",
        "drug",
        "fight",
        "cancer",
        "generating",
        "exciting",
        "result",
        "patient",
        "significant",
        "value",
        "biotech",
        "investor",
        "problem",
        "potential",
        "blockbuster",
        "drug",
        "miss",
        "mark",
        "cancer",
        "specialist",
        "incyte",
        "announced"
    ]
}